Ep 31 - The Amit Episode: Pitching HIMS to a Long-Time Skeptic
Description
In this episode of Hims House, Jonathan Stern, Patrick Lester (Bayside), and Nate Endicott sit down with Amit, one of the most notable names on fintwit and long-time skeptic of Hims. While Amit was early to Palantir and Robinhood, he’s unconvinced by Hims — and this episode is all about changing that. The crew makes the bull case: Hims’ 10-year vision, vertical integration, brand moat, and recent moves in weight loss, lab testing, peptides, and more. Amit pushes back, questioning the company’s tech DNA, long-term edge, and differentiation from giants like Amazon. They debate everything from customer retention and GLP-1 demand to regulatory chaos, and how the Hims retail investor community is rivaling institutional coverage.
00:00 Intro
00:38 Why Is Amit Even Here?!
01:22 Amit’s First Impressions of Hims
03:12 Laying Out the 10-Year Vision
08:36 "No Moat"
14:33 Vertical Integration
20:19 Hims as a Tech Company
25:32 Customer Retention, CAC, and LTV
34:31 Regulatory Chaos
35:22 Eli Lilly + Novo Nordisk Partnerships
36:42 Hims Earnings and Speculations
38:32 GLP-1 Market Dynamics
46:27 Building a Retail Community
51:04 Retail vs. Institutions
58:36 Volatility and Trading Strategies
01:06:10 Final Thoughts
Get full access to Hims House at himshouse.substack.com/subscribe
United States
